It Starts With
The Science
Support for Continuous Disinfection
While the healthcare industry has made significant advances to the cleaning and disinfection protocols under the training and monitoring of infection prevention teams, healthcare-associated infections still occur. Industry leaders have identified areas of concern and research calls for new, continuous or persistent disinfection technology.¹
It is important to develop either methods of continuous disinfection or a germicide with persistent antimicrobial effectiveness.¹
-William A. Rutala, PhD, MPH
Areas of Concern
- Recontamination
- Air Quality
Designed for Healthcare
When it comes to Healthcare-Associated Infections (HAIs,) we know there is no silver bullet. At ActivePure Medical, we believe in taking a bundled approach, which is why our engineers enhanced ActivePure Technology to specifically design a supplemental solution for the healthcare environment.
Supplemental Disinfection Technology
Continuous Disinfection
Whole-Hospital Coverage
No Labor Required
- Supplemental Disinfection Technology
- Continuous Disinfection
- Whole-Hospital Coverage
- No Labor Required
Class ll Medical Device
With the ActivePure Medical Guardian fully developed, ActivePure begin the multi-year process of Food and Drug Administration Review. Through rigorous testing, we proved to be effective against a broad spectrum of pathogens, as tested.¹
Staphylococcus epidermidis (gram-positive) Bacteria
6-log Reduction After 60-Minutes
Aspergillus niger (fungal mold)
4-log Reduction After 60-Minutes
Bacillus globigii (spore-forming)
4-log Reduction After 60-Minutes
Erwinia herbicola (gram-negative) Bacteria
5-log Reduction After 60-Minutes
MS2 Bacteriophage RNA Non-Enveloped Virus
6-log Reduction After 60-Minutes
Evidence-Based
With a team of experienced infection prevention professionals formed, the ActivePure Medical team went to work to further develop the evidence-based science behind the ActivePure Technology.¹ Our team believed the scientifically defendable evidence was required to validate our technology worked not only in laboratory settings, but also in the healthcare settings it was designed for. We believed it so much that we incorporated it into its official tagline.
Healthcare Inspired, Science Powered
Clinical Evidence
We partner with our customers to develop a robust clinical study measuring the impact of ActivePure in their facility. Below, we’ve outlined some recent studies we’ve concluded.
Medical-Surgical Intensive Care Unit
(MSICU)
Research shows that the risk for an HAI is higher when surfaces are contaminated with 500 CFUs or greater.¹
- 99.8% Decrease in Fungal CFUs on Surfaces
- 97.7% Decrease in the Microbial Burden on Floors
- 95.9% Decrease of Surface Microbial Burden
- 92.0% Decrease in the Number of Surfaces That Had Greater Than 500 CFUs
Surgical ICU (SICU) and Cardiovascular ICU (CV-ICU)
Surface Methicillin-Resistant Staphylococcus (MRSA) were Below Detection Levels (BDL) with the exception of single instance with 100% reduction.
- 97% Reduction of Surface Staphylococcus Aureus
- 87% Reduction of Surface Fungi
- 83% Reduction of surface Bacteria Counts
- 64% Reduction of Airborne Particulates